Cardiogenes
Country not established
- Devices
- 20
What Cardiogenes makes
Cardiogenes manufactures laser-based medical devices for tissue ablation and surgical procedures, including fiberoptic delivery systems and handheld probes for precise energy application. Their products include systems like the Eclipse series for general and urology-specific use, as well as photodynamic laser therapy (PLDT) kits for targeted tissue treatment. The company also produces the CrossFire system for controlled tissue modification and the PowerSculptor probes for sculpting or reshaping tissue.
The company’s devices are classified as Class II under FDA regulations and are authorised via the 510(k) clearance process. These products are listed in the FDA’s 510(k) registry, reflecting their compliance with US medical device standards. Cardiogenes operates as a US-based manufacturer.
Catalogue
Search and filter all 20 devicesFrequently asked questions
How many devices does Cardiogenes have in the registry?
The registry currently lists 20 devices for Cardiogenes. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cardiogenes's devices?
Among its 20 most recently registered devices, Cardiogenes has devices listed in FDA 510(k) (20 devices).
What risk classes do Cardiogenes's devices fall under?
Among its 20 most recently registered devices, the classes recorded for Cardiogenes's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cardiogenes in the registry?
The most recently registered devices listed for Cardiogenes include POWERSCULPTOR PROBES, ECLIPSE LAZERBLADE(TM) FIBEROPTIC DELIVERY SYSTEM, ECLIPSE 3200 and SUNRISE TECHNOLOGIES MODEL 5020 PLDD KIT.